HALEOSLABS logo

Haleos LABS Limited

HALEOSLABS·NSE·
1,480.00 +15.20 (+1.04%)
Market Cap452.98 Cr
PE Ratio25.85
Volume1,374
Day High - Low1542.00 - 1465.00
52W High-Low1774.00 - 1091.10
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
8.44%
Average
P/E
25.85x
Fair
Debt / Equity
0.44
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Weak

Price performance

Day1465
1542
52W1091
1774
DocStoX take

Supported by momentum (6.0), but held back by valuation (2.9).

DocStoX score

Low confidence
4.3
/10
Weak
Quality
Modest
ROE 8.4%
Valuation
Expensive
P/E 25.9×
Growth
Slow
Revenue +4.7% 5Y CAGR
Risk
Moderate
D/E 0.44
Momentum
Firm
57% of 52-week range

At a glance

Market Cap
₹453 Cr
52W High / Low
₹1774 / ₹1091
Dividend Yield
0.10%
Promoter Holding
72.11%
EPS (TTM)
₹57.26
Book Value
₹706.00

Key highlights

  • Profitable in all of the last 5 years
  • Small ₹453 cr company — thinner liquidity
1 Positive1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

HALEOS LABS LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.